Publication: Association between HNP1-3 and atherosclerotic plaque burden in subclinical atherosclerosis and the mediating effect of PCSK9
| dc.contributor.department | School of Medicine | |
| dc.contributor.department | KUTTAM (Koç University Research Center for Translational Medicine) | |
| dc.contributor.kuauthor | Yurtseven, Ece | |
| dc.contributor.kuauthor | Baysal, Kemal | |
| dc.contributor.kuauthor | İncir, Said | |
| dc.contributor.kuauthor | Canbaz, Ata Alpay | |
| dc.contributor.kuauthor | Veznikli, Mert | |
| dc.contributor.kuauthor | Baygül, Arzu Eden | |
| dc.contributor.kuauthor | Aslan, Gamze | |
| dc.contributor.kuauthor | Demirci, Yasemin | |
| dc.contributor.kuauthor | Gürsoy, Erol | |
| dc.contributor.kuauthor | Atasoy, Kayhan Çetin | |
| dc.contributor.kuauthor | Ural, Dilek | |
| dc.contributor.schoolcollegeinstitute | SCHOOL OF MEDICINE | |
| dc.contributor.schoolcollegeinstitute | Research Center | |
| dc.date.accessioned | 2025-12-31T08:19:06Z | |
| dc.date.available | 2025-12-31 | |
| dc.date.issued | 2025 | |
| dc.description.abstract | Subclinical atherosclerosis is a key predictor of cardiovascular events. While inflammation plays a crucial role in atherosclerosis, the involvement of Human Neutrophil Peptides 1–3 (HNP1-3) in its progression remains unclear. The study investigates the association of HNP1-3 and PCSK9 with coronary atherosclerotic burden and explores the potential mediatory role of PCSK9 in HNP1-3's effect on atherogenesis. Patients who underwent coronary computed tomographic angiography (CCTA) and had subclinical atherosclerosis (luminal stenosis < 50%) or normal coronary arteries were included in this cross-sectional study. HNP1-3 and PCSK9 levels were measured using ELISA, and coronary plaque burden was quantified using the modified Gensini score. Patients with subclinical atherosclerosis had significantly higher levels of HNP1-3 (p < 0.001), PCSK9 (p < 0.001), and lipoprotein(a) [Lp(a)] (p < 0.001) compared to controls. HNP1-3 was an independent predictor of subclinical atherosclerosis (p < 0.001), and its levels positively correlated with the modified Gensini score (p < 0.001). In multinomial logistic regression, higher levels of HNP1-3, PCSK9, and Lp(a) were independently associated with higher modified Gensini score tertiles. Mediation analysis revealed that PCSK9 mediated 48.7% of the effect of HNP1-3 on the modified Gensini score. After adjusting for hsCRP and cardiovascular risk factors, the direct effect of HNP1-3 became statistically insignificant, while the indirect effect via PCSK9 remained significant, suggesting that PCSK9 fully mediates the pro-atherogenic effects of HNP1-3. In conclusion, HNP1-3 is a novel independent predictor of subclinical atherosclerosis and coronary plaque burden, with its effects being mediated through PCSK9. These findings suggest that targeting PCSK9 could mitigate the inflammatory actions of HNP1-3, offering potential therapeutic insights for atherosclerosis prevention. | |
| dc.description.fulltext | No | |
| dc.description.harvestedfrom | Manual | |
| dc.description.indexedby | WOS | |
| dc.description.indexedby | Scopus | |
| dc.description.indexedby | PubMed | |
| dc.description.openaccess | All Open Access; Gold Open Access; Green Accepted Open Access; Green Open Access | |
| dc.description.publisherscope | International | |
| dc.description.readpublish | N/A | |
| dc.description.sponsoredbyTubitakEu | N/A | |
| dc.description.sponsorship | This work was supported by Koç University School of Medicine through funding for the purchase of HNP1-3 and PCSK9 ELISA kits. | |
| dc.identifier.doi | 10.1111/cts.70369 | |
| dc.identifier.eissn | 1752-8054 | |
| dc.identifier.embargo | No | |
| dc.identifier.isbn | 9780123736390 | |
| dc.identifier.issn | 1752-8062 | |
| dc.identifier.issue | 10 | |
| dc.identifier.pubmed | 41024518 | |
| dc.identifier.quartile | Q2 | |
| dc.identifier.scopus | 2-s2.0-105017517462 | |
| dc.identifier.uri | https://doi.org/10.1111/cts.70369 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14288/31433 | |
| dc.identifier.volume | 18 | |
| dc.identifier.wos | 001585420500001 | |
| dc.keywords | Atherosclerotic plaque burden | |
| dc.keywords | HNP1-3 | |
| dc.keywords | PCSK9 | |
| dc.keywords | Subclinical atherosclerosis | |
| dc.language.iso | eng | |
| dc.publisher | Wiley | |
| dc.relation.affiliation | Koç University | |
| dc.relation.collection | Koç University Institutional Repository | |
| dc.relation.ispartof | Clinical and Translational Science | |
| dc.relation.openaccess | No | |
| dc.rights | Copyrighted | |
| dc.subject | Research and experimental medicine | |
| dc.title | Association between HNP1-3 and atherosclerotic plaque burden in subclinical atherosclerosis and the mediating effect of PCSK9 | |
| dc.type | Journal Article | |
| dspace.entity.type | Publication | |
| person.familyName | Yurtseven | |
| person.familyName | Baysal | |
| person.familyName | İncir | |
| person.familyName | Canbaz | |
| person.familyName | Veznikli | |
| person.familyName | Baygül | |
| person.familyName | Aslan | |
| person.familyName | Demirci | |
| person.familyName | Gürsoy | |
| person.familyName | Atasoy | |
| person.familyName | Ural | |
| person.givenName | Ece | |
| person.givenName | Kemal | |
| person.givenName | Said | |
| person.givenName | Ata Alpay | |
| person.givenName | Mert | |
| person.givenName | Arzu Eden | |
| person.givenName | Gamze | |
| person.givenName | Yasemin | |
| person.givenName | Erol | |
| person.givenName | Kayhan Çetin | |
| person.givenName | Dilek | |
| relation.isOrgUnitOfPublication | d02929e1-2a70-44f0-ae17-7819f587bedd | |
| relation.isOrgUnitOfPublication | 91bbe15d-017f-446b-b102-ce755523d939 | |
| relation.isOrgUnitOfPublication.latestForDiscovery | d02929e1-2a70-44f0-ae17-7819f587bedd | |
| relation.isParentOrgUnitOfPublication | 17f2dc8e-6e54-4fa8-b5e0-d6415123a93e | |
| relation.isParentOrgUnitOfPublication | d437580f-9309-4ecb-864a-4af58309d287 | |
| relation.isParentOrgUnitOfPublication.latestForDiscovery | 17f2dc8e-6e54-4fa8-b5e0-d6415123a93e |
